首页 | 本学科首页   官方微博 | 高级检索  
     

组胺与固有免疫细胞分化在冠心病研究中的新认识
引用本文:许莉莉,朱宝玲,杨向东. 组胺与固有免疫细胞分化在冠心病研究中的新认识[J]. 中国动脉硬化杂志, 2019, 27(5): 369-373
作者姓名:许莉莉  朱宝玲  杨向东
作者单位:复旦大学附属中山医院上海市心血管病研究所
基金项目:国家自然科学基金(81370402、91439121);科技部重点研发计划(2016YFC1101102);上海市青年科技英才扬帆计划(18YF1404800)
摘    要:冠状动脉粥样硬化性心脏病(CHD)是一种常见的临床慢性心脏疾病。上世纪九十年代提出的动脉粥样硬化(As)"炎症学说",已成为心血管领域的基础和转化医学研究热点之一。炎症与免疫反应在As的炎症微环境形成中发挥了关键的作用,异常的免疫反应促进了As的发生,影响了急性心肌梗死后的心肌损伤和组织修复。组胺(histamine)是一个具有多种生物学活性的小分子化学物质,参与机体多样的生理和病理作用。组胺对固有免疫细胞和适应免疫细胞的分化和功能均有重要的调控作用,参与CHD的发生发展。组胺及其细胞内下游信号分子,成为CHD靶向药物研发的重要参考。

关 键 词:组胺  固有免疫细胞分化  冠心病  动脉粥样硬化  缺血性心肌病
收稿时间:2018-11-20
修稿时间:2018-12-15

New insights into histamine and innate immune cell differentiation in coronary heart disease
XU Lili,ZHU Baoling and YANG Xiangdong. New insights into histamine and innate immune cell differentiation in coronary heart disease[J]. Chinese Journal of Arteriosclerosis, 2019, 27(5): 369-373
Authors:XU Lili  ZHU Baoling  YANG Xiangdong
Affiliation:Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai 200032, China,Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai 200032, China and Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Abstract:Coronary atherosclerotic heart disease (CHD) is a common clinical chronic heart disease. Inflammation and immune response play pivotal roles in the development of atherosclerosis and ischemic myocardial diseases, and have become the focuses of cardiovascular disease research. Abnormal inflammatory immune response promotes atherogenesis and affects myocardial injury and tissue repair after acute myocardial infarction. Histidine decarboxylase (HDC) is the unique enzyme responsible for histamine generation. Histamine is a biogenic amine that has multiple functions through the activation of its widely distributed histamine receptors. Histamine regulates the differentiation and function of innate immune cells and adaptive immune cells. Recent studies have identified the new cellular source of histamine in immune cells and in ischemic myocardial injury. Targeting histamine and its downstream signaling molecules may provide new research strategies for the prevention and treatment of coronary heart disease.
Keywords:histamine   innate immune cell differentiation   coronary heart disease   atherosclerosis   ischemic cardiomyopathy
本文献已被 CNKI 等数据库收录!
点击此处可从《中国动脉硬化杂志》浏览原始摘要信息
点击此处可从《中国动脉硬化杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号